Skandinaviska Enskilda Banken (SEB)’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-30,400
Closed -$1.2M 898
2023
Q4
$1.2M Buy
30,400
+9,400
+45% +$393K 0.01% 670
2023
Q3
$932K Buy
21,000
+11,200
+114% +$489K 0.01% 684
2023
Q2
$426K Buy
9,800
+4,300
+78% +$189K ﹤0.01% 803
2023
Q1
$239K Buy
+5,500
New +$243K ﹤0.01% 817
2022
Q2
Sell
-7,800
Closed -$309K 1051
2022
Q1
$309K Hold
7,800
﹤0.01% 863
2021
Q4
$327K Buy
7,800
+4,800
+160% +$209K ﹤0.01% 875
2021
Q3
$127K Buy
+3,000
New +$151K ﹤0.01% 950
2021
Q1
Sell
-27,100
Closed -$1.16M 1174
2020
Q4
$1.16M Buy
27,100
+16,600
+158% +$852K 0.01% 782
2020
Q3
$517K Buy
+10,500
New +$581K ﹤0.01% 822

Other funds holding NRC

Skandinaviska Enskilda Banken (SEB)'s NRC Position: Q1 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of NRC Health Common Stock (NRC) in Q1 2024, closing a stake of 30,400 shares — an estimated $1.2M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in NRC in Q3 2020 and held it in 9 quarters. The position peaked at $1.2M in Q4 2023. 142 funds tracked by Wall St. Rank hold NRC as of Q1 2024.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining NRC Health Common Stock position as of Q1 2024 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 30,400 NRC Health Common Stock shares in Q1 2024, an estimated $1.2M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in NRC Health Common Stock in Q3 2020 and held it in 9 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s NRC Health Common Stock position peaked at $1.2M in Q4 2023.
  • 142 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2024, filed 13 May 2024.